Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers

Addictive Behaviors

Volumn 38, Issue 2, 2013, Pages 1518-1526

  Yoon, Jin H ^a   Newton, Thomas F ^a   Haile, Colin N ^a   Bordnick, Patrick S ^b   Fintzy, Rachel E ^a   Culbertson, Chris ^a   Mahoney, James J ^a   Hawkins, Rollin Y ^a   LaBounty, Kathleen R ^a   Ross, Elizabeth L ^a   Aziziyeh, Adel I ^a   La Garza, Richard De ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Cocaine; Cognitive behavioral therapy; Craving; Cues; D cycloserine; Nicotine

Indexed keywords

CARBON MONOXIDE; CYCLOSERINE; PLACEBO;

ADULT; ARTHRITIS; ARTICLE; ASSOCIATION; CLINICAL ARTICLE; COCAINE DEPENDENCE; COGNITIVE THERAPY; COLD; COUGHING; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INTENTION TO TREAT ANALYSIS; MALE; PAIN; SELF REPORT; SIDE EFFECT; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; VOMITING; WITHDRAWAL SYNDROME;

EID: 84871762160     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2012.03.022     Document Type: Article

References (60)

1. Baker A., Lee N.K., Claire M., Lewin T.J., Grant T., Pohlman S., et al. Brief cognitive behavioural interventions for regular amphetamine users: A step in the right direction. Addiction 2005, 100(3):367-378.
2. Baumann S.B., Sayette M.A. Smoking cues in a virtual world provoke craving in cigarette smokers. Psychology of Addictive Behaviors 2006, 20(4):484-489.
3. Benowitz N.L., Peyton J.I., Ahijevych K.L., Jarvis M.J., Hall S., LeHouezec J., et al. Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research 2002, 4(2):149-159.
4. Bliss R.E., Garvey A.J., Heinold J.W., Hitchcock J.L. The influence of situation and coping on relapse crisis outcomes after smoking cessation. Journal of Consulting and Clinical Psychology 1989, 57(3):443-449.
5. Bordnick P.S., Graap K.M., Copp H.L., Brooks J., Ferrer M. Virtual reality cue reactivity assessment in cigarette smokers. Cyberpsychology & Behavior 2005, 8(5):487-492.
6. Bordnick P.S., Graap K.M., Copp H., Brooks J., Ferrer M., Logue B. Utilizing virtual reality to standardize nicotine craving research: A pilot study. Addictive Behaviors 2004, 29(9):1889-1894.
7. Bordnick P.S., Traylor A., Copp H.L., Graap K.M., Carter B., Ferrer M., et al. Assessing reactivity to virtual reality alcohol based cues. Addictive Behaviors 2008, 33(6):743-756.
8. Bordnick P.S., Traylor A.C., Graap K.M., Copp H.L., Brooks J. Virtual reality cue reactivity assessment: A case study in a teen smoker. Applied Psychophysiology and Biofeedback 2005, 30(3):187-193.
9. Budney A.J., Higgins S.T., Hughes J.R., Bickel W.K. Nicotine and caffeine use in cocaine-dependent individuals. Journal of Substance Abuse 1993, 5(2):117-130.
10. Burling T.A., Salvio M.A., Seidner A.L., Ramsey T.G. Cigarette smoking in alcohol and cocaine abusers. Journal of Substance Abuse 1996, 8(4):445-452.
11. Caggiula A.R., Donny E.C., Chaudhri N., Perkins K.A., Evans-Martin F.F., Sved A.F. Importance of nonpharmacological factors in nicotine self-administration. Physiology & Behavior 2002, 77(4-5):683-687.
12. Carroll K.M. Relapse prevention as a psychosocial treatment approach: A review of controlled clinical trials. Experimental and Clinical Psychopharmacology 1996, 4:46-54.
13. Carroll K.M., Onken L.S. Behavioral therapies for drug abuse. The American Journal of Psychiatry 2005, 162(8):1452-1460.
14. Carter B.L., Bordnick P., Traylor A., Day S.X., Paris M. Location and longing: The nicotine craving experience in virtual reality. Drug and Alcohol Dependence 2008, 95(1-2):73-80.
15. Copeland J., Swift W., Roffman R., Stephens R. A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. Journal of Substance Abuse Treatment 2001, 21(2):55-64. discussion 65-56.
16. Culbertson C., Nicolas S., Zaharovits I., London E.D., La Garza R.D., Brody A.L., et al. Methamphetamine craving induced in an online virtual reality environment. Pharmacology, Biochemistry, and Behavior 2010, 96(4):454-460.
17. Davis M., Ressler K., Rothbaum B.O., Richardson R. Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biological Psychiatry 2006, 60(4):369-375.
18. Ferguson S.G., Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. Journal of Substance Abuse Treatment 2009, 36(3):235-243.
19. Fiore M.C., Jaen C.R., Baker T.P., Bailey W.C., Benowitz N.L., Curry S.J., et al. Treating tobacco use and dependency: 2008 update clinical practice guideline 2008.
20. Ganasen K.A., Ipser J.C., Stein D.J. Augmentation of cognitive behavioral therapy with pharmacotherapy. The Psychiatric Clinics of North America 2010, 33(3):687-699.
21. Gorelick D.A., Simmons M.S., Carriero N., Tashkin D.P. Characteristics of smoked drug use among cocaine smokers. The American Journal on Addictions 1997, 6(3):237-245.
22. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction 1991, 86(9):1119-1127.
23. Heldt S.A., Green A., Ressler K.J. Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychopharmacology 2004, 29(9):1610-1619.
24. Hofmann S.G., Meuret A.E., Smits J.A., Simon N.M., Pollack M.H., Eisenmenger K., et al. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Archives of General Psychiatry 2006, 63(3):298-304.
25. Hser Y.I., McCarthy W.J., Anglin M.D. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Preventive Medicine 1994, 23(1):61-69.
26. Hughes J.R., Keely J., Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004, 99(1):29-38.
27. Hurt R.D., Offord K.P., Croghan I.T., Gomez-Dahl L., Kottke T.E., Morse R.M., et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA: The Journal of the American Medical Association 1996, 275(14):1097-1103.
28. Jarvik M.E., Madsen D.C., Olmstead R.E., Iwamoto-Schaap P.N., Elins J.L., Benowitz N.L. Nicotine blood levels and subjective craving for cigarettes. Pharmacology, Biochemistry, and Behavior 2000, 66(3):553-558.
29. Kalman D., Morissette S.B., George T.P. Co-morbidity of smoking in patients with psychiatric and substance use disorders. The American Journal on Addictions 2005, 14(2):106-123.
30. Kamboj S.K., Joye A., Das R.K., Gibson A.J., Morgan C.J., Curran H.V. Cue exposure and response prevention with heavy smokers: A laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias. Psychopharmacology 2011.
31. Kamboj S.K., Massey-Chase R., Rodney L., Das R., Almahdi B., Curran H.V., et al. Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: A laboratory study of the effects of D-cycloserine in heavy drinkers. Psychopharmacology 2011, 217(1):25-37.
32. Kantak K.M., Nic Dhonnchadha B.A. Pharmacological enhancement of drug cue extinction learning: Translational challenges. Annals of the New York Academy of Sciences 2011, 1216:122-137.
33. Kuntze M.F., Stoermer R., Mager R., Roessler A., Mueller-Spahn F., Bullinger A.H. Immersive virtual environments in cue exposure. Cyberpsychology & Behavior 2001, 4(4):497-501.
34. Langton J.M., Richardson R. D-cycloserine facilitates extinction the first time but not the second time: An examination of the role of NMDA across the course of repeated extinction sessions. Neuropsychopharmacology: Official publication of the American College of Neuropsychopharmacology 2008, 33(13):3096-3102. [Research Support, Non-U.S. Gov't].
35. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: A population-based prevalence study. JAMA : The Journal of the American Medical Association 2000, 284(20):2606-2610.
36. Ledgerwood L., Richardson R., Cranney J. D-cycloserine and the facilitation of extinction of conditioned fear: Consequences for reinstatement. Behavioral Neuroscience 2004, 118(3):505-513.
37. Lee J.H., Ku J., Kim K., Kim B., Kim I.Y., Yang B.H., et al. Experimental application of virtual reality for nicotine craving through cue exposure. Cyberpsychology & Behavior 2003, 6(3):275-280.
38. Lee J.H., Kwon H., Choi J., Yang B.H. Cue-exposure therapy to decrease alcohol craving in virtual environment. Cyberpsychology & Behavior 2007, 10(5):617-623.
39. Lee J.H., Lim Y., Wiederhold B.K., Graham S.J. A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments. Applied Psychophysiology and Biofeedback 2005, 30(3):195-204.
40. Martina M., Gorfinkel Y., Halman S., Lowe J.A., Periyalwar P., Schmidt C.J., et al. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. The Journal of Physiology 2004, 557(Pt 2):489-500.
41. Morisano D., Bacher I., Audrain-McGovern J., George T.P. Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Canadian Journal of Psychiatry 2009, 54(6):356-367.
42. Patkar A.A., Batra V., Mannelli P., Evers-Casey S., Vergare M.J., Leone F.T. Medical symptoms associated with tobacco smoking with and without marijuana abuse among crack cocaine-dependent patients. The American Journal on Addictions 2005, 14(1):43-53.
43. Patkar A.A., Lundy A., Leone F.T., Weinstein S.P., Gottheil E., Steinberg M. Tobacco and alcohol use and medical symptoms among cocaine dependent patients. Substance Abuse 2002, 23(2):105-114.
44. Patkar A.A., Mannelli P., Peindl K., Murray H.W., Meier B., Leone F.T. Changes in tobacco smoking following treatment for cocaine dependence. The American Journal of Drug and Alcohol Abuse 2006, 32(2):135-148.
45. Patkar A.A., Sterling R.C., Leone F.T., Lundy A., Weinstein S.P. Relationship between tobacco smoking and medical symptoms among cocaine-, alcohol-, and opiate-dependent patients. The American Journal on Addictions 2002, 11(3):209-218.
46. Perkins K.A. Does smoking cue-induced craving tell us anything important about nicotine dependence?. Addiction 2009, 104(10):1610-1616.
47. Poling J., Rounsaville B., Gonsai K., Severino K., Sofuoglu M. The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study. The American Journal on Addictions 2010, 19(5):401-408.
48. Price K.L., McRae-Clark A.L., Saladin M.E., Maria M.M., DeSantis S.M., Back S.E., et al. D-cycloserine and cocaine cue reactivity: Preliminary findings. The American Journal of Drug and Alcohol Abuse 2009, 35(6):434-438.
49. Prochaska J.J., Delucchi K., Hall S.M. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology 2004, 72(6):1144-1156.
50. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., et al. Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry 2004, 61(11):1136-1144.
51. Rose J.E. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 2006, 184(3-4):274-285.
52. Rothbaum B.O. Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder. The American Journal of Psychiatry 2008, 165(3):293-296.
53. Santa Ana E.J., Rounsaville B.J., Frankforter T.L., Nich C., Babuscio T., Poling J., et al. D-cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: A pilot investigation. Drug and Alcohol Dependence 2009, 104(3):220-227.
54. Shiffman S. Relapse following smoking cessation: A situational analysis. Journal of Consulting and Clinical Psychology 1982, 50(1):71-86.
55. Shiffman S., Engberg J.B., Paty J.A., Perz W.G., Gnys M., Kassel J.D., et al. A day at a time: Predicting smoking lapse from daily urge. Journal of Abnormal Psychology 1997, 106(1):104-116.
56. Shiffman S., Paty J.A., Gnys M., Kassel J.A., Hickcox M. First lapses to smoking: Within-subjects analysis of real-time reports. Journal of Consulting and Clinical Psychology 1996, 64(2):366-379.
57. Traylor A.C., Bordnick P.S., Carter B.L. Assessing craving in young adult smokers using virtual reality. The American Journal on Addictions 2008, 17(5):436-440.
58. Traylor A.C., Bordnick P.S., Carter B.L. Using virtual reality to assess young adult smokers' attention to cues. Cyberpsychology & Behavior 2009, 12(4):373-378.
59. Watson B.J., Wilson S., Griffin L., Kalk N.J., Taylor L.G., Munafo M.R., et al. A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects. Psychopharmacology 2011, 216(1):121-129.
60. Weinberger A.H., Sofuoglu M. The impact of cigarette smoking on stimulant addiction. The American Journal of Drug and Alcohol Abuse 2009, 35(1):12-17.